Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTRA | Common Stock | Award | $0 | +21.7K | +44.28% | $0.00 | 70.8K | Feb 21, 2023 | Direct | F1 |
holding | CTRA | Common Stock | 0 | Feb 21, 2023 | Held in 401(k) | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTRA | Performance Shares | Award | $0 | +21.7K | $0.00 | 21.7K | Feb 21, 2023 | Common | 21.7K | Direct | F3 |
Id | Content |
---|---|
F1 | These shares represent restricted stock units payable solely in common stock on January 31, 2026, subject to continued employment, earlier retirement under company policy or, in certain cases, pro-rata reduction in shares for time actually employed in the period from the grant date to the vesting date. |
F2 | Effective December 28, 2022, the issuer eliminated CTRA stock as an investment alternative available under the issuer's 401(k) plan. As a result, the 15,615 shares of CTRA common stock the reporting person previously reported as beneficially owned under the plan were liquidated. |
F3 | The performance shares provide for vesting between 0% and 200% of the performance shares awarded (payable in common stock and, for vesting above 100%, in cash) based upon certain performance criteria over a three-year performance period beginning February 1, 2023 and ending January 31, 2026. |